Duloxetine alleviates oxaliplatin-induced peripheral neuropathy by regulating p53-mediated apoptosis

被引:2
作者
Wang, Man [1 ]
Zhang, Ling [1 ]
Liu, Xiaoli [1 ]
Qiu, Siyan [1 ]
Xu, Rong [1 ]
Yang, Chao [1 ]
Lu, Yuting [1 ]
Zhang, Peng [1 ]
Yan, Ming [1 ]
Zhu, Jing [1 ,2 ]
机构
[1] Nanjing Univ Chinese Med, Sch Pharm, Jiangsu Key Lab Pharmacol & Safety Evaluat Chines, 138 Xianlin Ave, Nanjing 210023, Jiangsu, Peoples R China
[2] Johns Hopkins Sch Med, Dept Neurol & Neurosci, Baltimore, MD USA
关键词
duloxetine; neuronal apoptosis; oxaliplatin; p53; peripheral neuropathy; EXPRESSION; DENSITY; P53;
D O I
10.1097/WNR.0000000000001802
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Oxaliplatin (OXA) is a key platinum-based chemotherapeutic agent for treatment of metastatic colorectal cancer, but the side effects of acute and chronic neuropathies limit its clinical application. Duloxetine has been found to have the potential to prevent OXA-induced peripheral neuropathy in several studies, but the underlying mechanisms remain unclear. The purpose of this study was to evaluate the effects of duloxetine on OXA-induced peripheral neuropathy and to find the potential mechanisms. The neuropathic pain mice model was used to explore the role of duloxetine on OXA-induced peripheral neuropathy by measuring the change of thermal withdrawal latency (TWL), paw withdrawal threshold (PWT), and intraepidermal nerve fiber density (IENFD). Moreover, to explore molecular mechanisms, effects of duloxetine on OXA-induced changes in mRNA and protein expression of components of the p53-related pathways in cultured rat dorsal root ganglion (DRG) neurons were measured. In vivo, we found duloxetine treatment could significantly prevent the changes in the TWL, PWT to mechanical stimulation, and the IENFD of mice caused by OXA. In vitro, we found duloxetine notably inhibits the relative mRNA and protein expression levels of p53, Bax/Bcl2, caspase-3, and caspase-9 in DRG neurons, which may indicate duloxetine protected the DRG neuron by inhibiting p53-related pathways. These results suggest that duloxetine could alleviate the OXA-induced peripheral neuropathy. Duloxetine deserves further consideration as a potential protective agent against peripheral neuropathy. Copyright (C) 2022 Wolters Kluwer Health. Inc. All rights reserved.
引用
收藏
页码:437 / 444
页数:8
相关论文
共 50 条
[41]   Transcriptional activation of miR-34a contributes to p53-mediated apoptosis [J].
Raver-Shapira, Nina ;
Marciano, Efi ;
Meiri, Eti ;
Spector, Yael ;
Rosenfeld, Nitzan ;
Moskovits, Neta ;
Bentwich, Zvi ;
Oren, Moshe .
MOLECULAR CELL, 2007, 26 (05) :731-743
[42]   Oxaliplatin-induced peripheral neuropathy risk factors and management in Tunisian population [J].
Zribi, Aref ;
Ben Nasr, Sonia ;
Hamdi, Syrine ;
Ayari, Jihen ;
Fendri, Sana ;
Balti, Mehdi ;
Haddaoui, Abderrazek .
PAN AFRICAN MEDICAL JOURNAL, 2020, 35
[43]   Impact of Dose, Sex, and Strain on Oxaliplatin-Induced Peripheral Neuropathy in Mice [J].
Warncke, Urszula O. ;
Toma, Wisam ;
Meade, Julie A. ;
Park, Abigail J. ;
Thompson, Danielle C. ;
Caillaud, Martial ;
Bigbee, John W. ;
Bryant, Camron D. ;
Damaj, M. Imad .
FRONTIERS IN PAIN RESEARCH, 2021, 2
[44]   Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment [J].
Lumei Kang ;
Yuyang Tian ;
Shilin Xu ;
Hongping Chen .
Journal of Neurology, 2021, 268 :3269-3282
[45]   Vascular dysfunction is at the onset of oxaliplatin-induced peripheral neuropathy symptoms in mice [J].
Taib, Sonia ;
Durand, Juliette ;
Dehais, Vianney ;
Boulay, Anne-Cecile ;
Martin, Sabrina ;
Blugeon, Corinne ;
Jourdren, Laurent ;
Freydier, Remi ;
Cohen-Salmon, Martine ;
Hazan, Jamile ;
Brunet, Isabelle .
LIFE SCIENCE ALLIANCE, 2024, 8 (02)
[46]   Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment [J].
Kang, Lumei ;
Tian, Yuyang ;
Xu, Shilin ;
Chen, Hongping .
JOURNAL OF NEUROLOGY, 2021, 268 (09) :3269-3282
[47]   Endothelial Glycocalyx in the Peripheral Capillaries is Injured Under Oxaliplatin-Induced Neuropathy [J].
Kuroda, Takahiro ;
Suzuki, Akio ;
Okada, Hideshi ;
Shimizu, Masayoshi ;
Watanabe, Daichi ;
Suzuki, Keiko ;
Mori, Kosuke ;
Ohmura, Kazufumi ;
Niwa, Ayumi ;
Imaizumi, Yuko ;
Matsuo, Mikiko ;
Ichihashi, Koki ;
Okubo, Takafumi ;
Taniguchi, Toshiaki ;
Kanayma, Tomohiro ;
Kobayashi, Ryo ;
Sugie, Shigeyuki ;
Hara, Akira ;
Tomita, Hiroyuki .
JOURNAL OF PAIN, 2024, 25 (06)
[48]   Pain in oxaliplatin-induced neuropathy - Sensitisation in the peripheral and central nociceptive system [J].
Binder, Andreas ;
Stengel, Maike ;
Maag, Rainer ;
Wasner, Gunnar ;
Schoch, Robert ;
Moosig, Frank ;
Schommer, Bernhard ;
Baron, Ralf .
EUROPEAN JOURNAL OF CANCER, 2007, 43 (18) :2658-2663
[49]   Properties of the Measures to Assess Oxaliplatin-induced Peripheral Neuropathy: A Literature Review [J].
Chu, Sang Hui ;
Lee, Yoon Ju ;
Lee, Young Joo ;
Cleeland, Charles S. .
JOURNAL OF KOREAN ACADEMY OF NURSING, 2015, 45 (06) :783-801
[50]   HCVNS5A interacts with p53 and inhibits p53-mediated apoptosis [J].
Lan, KH ;
Sheu, ML ;
Hwang, SJ ;
Yen, SH ;
Chen, SY ;
Wu, JC ;
Wang, YJ ;
Kato, N ;
Omata, M ;
Chang, FY ;
Lee, SD .
ONCOGENE, 2002, 21 (31) :4801-4811